Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India’s public sector

BACKGROUND: Truenat is a novel molecular assay that rapidly detects tuberculosis (TB) and rifampicin-resistance. Due to the portability of its battery-powered testing platform, it may be valuable in peripheral healthcare settings in India. METHODS: Using a microsimulation model, we compared four TB...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, David J., Kumarasamy, Nagalingeswaran, Resch, Stephen C., Sivaramakrishnan, Gomathi N., Mayer, Kenneth H., Tripathy, Srikanth, Paltiel, A. David, Freedberg, Kenneth A., Reddy, Krishna P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605662/
https://www.ncbi.nlm.nih.gov/pubmed/31265470
http://dx.doi.org/10.1371/journal.pone.0218890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605662/
https://www.ncbi.nlm.nih.gov/pubmed/31265470
http://dx.doi.org/10.1371/journal.pone.0218890

Ejemplares similares